Clinical Trial

A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function

Study acronym: NEMO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function. Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.
Trial Details
NCT Number NCT07133477
Lead Sponsor Epax Norway AS
Collaborators: Cutest Systems Ltd
Conditions Skin Health
Enrollment 90 participants
Start Date 2025-04-30
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-21